Eton Pharma acquires Galzin, an US FDA approved treatment of ultra-rare metabolic condition of Wilson disease: Deer Park, Illinois Monday, January 6, 2025, 15:00 Hrs [IST] Eton Ph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback